z-logo
open-access-imgOpen Access
Probucol Protects Endothelial Progenitor Cells Against Oxidized Low-Density Lipoprotein via Suppression of Reactive Oxygen Species Formation In Vivo
Author(s) -
Qingbin Zhang,
Liming Chen,
Zhihua Si,
Haoran Bu,
Chandrakala Aluganti Narasimhulu,
Xueling Song,
Mingyu Cui,
Hang Liu,
Tiewei Lu,
Guanglong He,
Sampath Parthasarathy,
Lianqun Cui,
Zhenguo Liu,
Yuqi Cui
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000445608
Subject(s) - probucol , reactive oxygen species , in vivo , progenitor cell , chemistry , microbiology and biotechnology , endothelial progenitor cell , endothelial stem cell , low density lipoprotein , progenitor , lipoprotein , oxygen , biochemistry , biophysics , in vitro , cholesterol , biology , stem cell , organic chemistry
Oxidized low-density lipoprotein (ox-LDL) is a major component of hyperlipidemia and contributes to atherosclerosis. Endothelial progenitor cells (EPCs) play an important role in preventing atherosclerosis and notably decreased in hyperlipidemia. Ox-LDL and ox-LDL-related reactive oxygen species (ROS) have deleterious effects on EPCs. Probucol as an antioxidant and anti-inflammatory drug reduces ROS production. The present study was to determine if probucol could protect EPCs from ox-LDL in vivo and to investigate the potential mechanisms.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom